Analyst Viewpoint
Rise in prevalence of obesity across the world is driving the global intragastric balloons market. Adoption of intragastric balloons among both patients and physicians has increased in the past few years. Clinically-proven efficacy along with minimal risk, pain, and recovery time are the major factors driving market expansion. Furthermore, increase in demand for minimally invasive weight-loss therapies is expected to bolster the global intragastric balloons industry during the forecast period.
Technological advancements such as volume-adjustable and swallowable balloons offer lucrative opportunities to market players. Manufacturers are focusing on developing cost efficient and higher efficacy intragastric balloons in order to increase market share.
Intragastric balloons are medical devices that are temporarily placed in the stomach to induce weight loss. Also known as stomach balloons or gastric balloons, these work by occupying space in the stomach which makes the patient feel full sooner. This helps reduce food intake, aiding in weight management.
Balloons are usually implanted endoscopically and kept inflated with saline solution inside the stomach for a fixed period, usually six months. Some self-deflating versions are also available. After the intended duration, these are removed either endoscopically or passively expelled from the body. Clinical studies have shown intragastric balloons can help patients lose 15% to 25% of their body weight when combined with lifestyle changes.
The global prevalence of obesity has increased dramatically in the last few decades. According to the WHO, obesity rates have nearly tripled since 1975. In 2016, more than 1.9 billion adults aged 18 years and older were overweight, and over 650 million were obese. If trends continue unabated, over 50% of the world's adult population is projected to be overweight or obese by 2030.
This alarming increase in obesity globally is driving demand for effective weight loss solutions. Adverse health impacts associated with obesity, such as diabetes, cardiovascular diseases, and certain cancers, have also highlighted the need for early clinical interventions.
Intragastric balloon is gaining prominence as non-invasive option for initial weight loss prior to bariatric procedures or as an alternative therapy for obese patients who are not candidates for surgery.
Demand for minimally invasive and low-risk weight loss methods has increased in the past few years. More people are looking for effective weight loss therapies that are less invasive and do not need substantial lifestyle changes or surgery. Thus, increase in inclination toward less disruptive weight control methods is fueling the intragastric balloons industry.
Intragastric balloons provide an outpatient weight loss procedure with rapid recovery duration and few post-operation limitations. Balloons are far less intrusive than bariatric operations, which need more hospitalization and difficult aftercare.
Balloon treatment is an appealing first-line choice for overweight individuals due to its low procedural risk and simplicity. Demand is even higher since that newer self-expandable models do not require endoscopic removal.
Rise in obesity awareness has also increased interest in novel weight loss procedures before undergoing surgery. Balloons offer clinically verified outcomes as a preliminary to more intrusive procedures or as an option for those who are ineligible.
Doctors are also inclined toward minimally invasive techniques that increase therapeutic availability. Advanced balloon designs with features such as volume control increase patient and physician trust.
Rise in emphasis on lifestyle-focused weight management coupled with growing acceptance of less complex options makes intragastric balloons the preferred minimally invasive weight loss solution. Their ability to deliver proven short-term efficacy while posing limited risks or hassle is driving the intragastric balloons market.
According to the latest intragastric balloons market trends, the fluid-filled balloons type segment is projected to account for dominant share from 2023 to 2031. This can be ascribed to their longer history of usage and proven safety record.
The first generation of balloons introduced in the 1980s were fluid-filled and helped establish clinical efficacy. Since then, extensive research and usage data have demonstrated a low risk profile with fluid versions.
Manufacturers are adept at producing fluid balloons, which enables low-cost mass production. This results in strong penetration in areas where pricing is a factor. Furthermore, there is no need for specific filling tools or training during implantation fluid balloons. Ease of use of these balloons improves accessibility in places with inadequate resources or expertise.
Despite the fact that gas balloons allow for volume modifications to better manage weight loss, worries about deflation or over-inflation still exist. The results are less definite than with steady static quantities of fluid balloons. Regulators also maintain stringent approval protocols for gas devices due to additional safety considerations.
In terms of end-user, the ambulatory surgery centers segment accounted for the largest global intragastric balloons market share in 2022. Ambulatory surgery centers (ASCs) are specialist outpatient clinics with emphasis on offering same-day surgery without the need for overnight stay in the hospital.
The ASC format is well suited for balloon treatments/procedures due to their non-invasive and low-risk nature. ASCs are preferred by patients because of benefits including planned procedures, easy access, personalized attention, and prevention of hospital-acquired infections and problems.
From an operational standpoint, ambulatory surgical centers are well-suited to manage the straightforward balloon deployments. This is a more economical way to manage an increasing amount of overweight caseloads than hospitals. The trend toward outpatient bariatrics has increased the need for ASCs as the preferred balloon treatment provider.
According to intragastric balloons market analysis, North America dominated the global industry in 2022. The market in the region is projected to grow at a rapid pace from 2023 to 2031. This can be ascribed to favorable demographic and economic conditions.
Adoption of minimally invasive weight reduction procedures is financially supported in the U.S. by reimbursement systems such as Medicare. Advanced medical infrastructure with a high number of bariatric clinics, trained specialists, and availability of devices conveniently places the region at the forefront of clinical balloon applications.
Europe has comparatively greater awareness levels of the health hazards associated with obesity and its management alternatives compared to other emerging countries. Developed economies have enabled greater focus on preventive healthcare measures. These factors have reinforced the region’s dominance of the intragastric balloons market.
Asia Pacific also recorded significant market development in 2022. The intragastric balloons market in the region is expected to grow at a rapid pace during the forecast period. This can be ascribed to large patient population in countries such as India and China, improvement in healthcare facilities, and rise in awareness about obesity, and its treatments. Additionally, surge in awareness about healthy body and fit mind among the population is fueling market demand in Asia Pacific.
The global intragastric balloons market is consolidated, with small number of key players accounting for majority share. Companies are investing significantly in R&D to expand product portfolio. Collaborations, partnerships, and mergers & acquisitions are key strategies adopted by the manufacturers.
Apollo Endosurgery, Inc., ReShape Lifesciences, Inc., Spatz FGIA, Inc., Allurion S.a.s., ENDALIS, Helioscopie, LEXEL S.R.L., and CSC MEDSIL are the prominent players in the global market.
Leading players have been profiled in the intragastric balloons market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Size in 2022 | US$ 55.5 Mn |
| Forecast (Value) in 2031 | US$ 160.7 Mn |
| Growth Rate (CAGR) | 12.2% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 55.5 Mn in 2022.
It is projected to reach US$ 160.7 Mn by 2031.
It is anticipated to advance at a CAGR of 12.2% from 2023 to 2031.
Rise in prevalence of obesity across the globe and increase in demand for minimally invasive weight-loss therapies.
The 6 months segment accounted for the largest share in 2022.
North America is expected to account for major share during the forecast period.
Apollo Endosurgery, Inc., ReShape Lifesciences, Inc., Spatz FGIA, Inc., Allurion S.a.s., ENDALIS, Helioscopie, LEXEL S.R.L., and CSC MEDSIL.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Intragastric Balloons Market
4. Market Overview
4.1. Introduction
4.1.1. Duration Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Intragastric Balloons Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events
5.2. Prevalence and Incidence of Obesity in the World
5.3. Regulatory Scenarion in Key Regions/Globally
5.4. Covid-19 Pandemic Impact on Industry
6. Global Intragastric Balloons Market Analysis and Forecast, by Duration
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Duration, 2017–2031
6.3.1. <6 Months
6.3.2. 6 Months
6.3.3. >6 Months
6.4. Market Attractiveness Analysis, by Duration
7. Global Intragastric Balloons Market Analysis and Forecast, by Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Type, 2017–2031
7.3.1. Fluid-filled Balloons
7.3.2. Gas-filled Balloons
7.4. Market Attractiveness Analysis, by Type
8. Global Intragastric Balloons Market Analysis and Forecast, by Administration
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Administration, 2017–2031
8.3.1. Endoscopy
8.3.2. Swallowable
8.4. Market Attractiveness Analysis, by Administration
9. Global Intragastric Balloons Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Specialty Clinics
9.4. Market Attractiveness Analysis, by End-user
10. Global Intragastric Balloons Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Intragastric Balloons Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Duration, 2017–2031
11.2.1. <6 Months
11.2.2. 6 Months
11.2.3. >6 Months
11.3. Market Value Forecast, by Type, 2017–2031
11.3.1. Fluid-filled Balloons
11.3.2. Gas-filled Balloons
11.4. Market Value Forecast, by Administration, 2017–2031
11.4.1. Endoscopy
11.4.2. Swallowable
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Specialty Clinics
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Duration
11.7.2. By Type
11.7.3. By Administration
11.7.4. By End-user
11.7.5. By Country
12. Europe Intragastric Balloons Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Duration, 2017–2031
12.2.1. <6 Months
12.2.2. 6 Months
12.2.3. >6 Months
12.3. Market Value Forecast, by Type, 2017–2031
12.3.1. Fluid-filled Balloons
12.3.2. Gas-filled Balloons
12.4. Market Value Forecast, by Administration, 2017–2031
12.4.1. Endoscopy
12.4.2. Swallowable
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Specialty Clinics
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Duration
12.7.2. By Type
12.7.3. By Administration
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Intragastric Balloons Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Duration, 2017–2031
13.2.1. <6 Months
13.2.2. 6 Months
13.2.3. >6 Months
13.3. Market Value Forecast, by Type, 2017–2031
13.3.1. Fluid-filled Balloons
13.3.2. Gas-filled Balloons
13.4. Market Value Forecast, by Administration, 2017–2031
13.4.1. Endoscopy
13.4.2. Swallowable
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Specialty Clinics
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Duration
13.7.2. By Type
13.7.3. By Administration
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Intragastric Balloons Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Duration, 2017–2031
14.2.1. <6 Months
14.2.2. 6 Months
14.2.3. >6 Months
14.3. Market Value Forecast, by Type, 2017–2031
14.3.1. Fluid-filled Balloons
14.3.2. Gas-filled Balloons
14.4. Market Value Forecast, by Administration, 2017–2031
14.4.1. Endoscopy
14.4.2. Swallowable
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Specialty Clinics
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Duration
14.7.2. By Type
14.7.3. By Administration
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Intragastric Balloons Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Duration, 2017–2031
15.2.1. <6 Months
15.2.2. 6 Months
15.2.3. >6 Months
15.3. Market Value Forecast, by Type, 2017–2031
15.3.1. Fluid-filled Balloons
15.3.2. Gas-filled Balloons
15.4. Market Value Forecast, by Administration, 2017–2031
15.4.1. Endoscopy
15.4.2. Swallowable
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers
15.5.3. Specialty Clinics
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Duration
15.7.2. By Type
15.7.3. By Administration
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Apollo Endosurgery, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. ReShape Lifesciences, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Spatz FGIA, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Allurion S.a.s.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. ENDALIS
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Helioscopie
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. LEXEL S.R.L.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. CSC MEDSIL
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
List of Tables
Table 1: Global Intragastric Balloons Market Value (US$ Mn) Forecast, by Duration, 2017–2031
Table 2: Global Intragastric Balloons Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 3: Global Intragastric Balloons Market Value (US$ Mn) Forecast, by Administration, 2017–2031
Table 4: Global Intragastric Balloons Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 5: Global Intragastric Balloons Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 6: North America Intragastric Balloons Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 7: North America Intragastric Balloons Market Value (US$ Mn) Forecast, by Duration, 2017–2031
Table 8: North America Intragastric Balloons Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 9: North America Intragastric Balloons Market Value (US$ Mn) Forecast, by Administration, 2017–2031
Table 10: North America Intragastric Balloons Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Intragastric Balloons Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Intragastric Balloons Market Value (US$ Mn) Forecast, by Duration, 2017–2031
Table 13: Europe Intragastric Balloons Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 14: Europe Intragastric Balloons Market Value (US$ Mn) Forecast, by Administration, 2017–2031
Table 15: Europe Intragastric Balloons Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Intragastric Balloons Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Intragastric Balloons Market Value (US$ Mn) Forecast, by Duration, 2017–2031
Table 18: Asia Pacific Intragastric Balloons Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 19: Asia Pacific Intragastric Balloons Market Value (US$ Mn) Forecast, by Administration, 2017–2031
Table 20: Asia Pacific Intragastric Balloons Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Latin America Intragastric Balloons Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Latin America Intragastric Balloons Market Value (US$ Mn) Forecast, by Duration, 2017–2031
Table 23: Latin America Intragastric Balloons Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 24: Latin America Intragastric Balloons Market Value (US$ Mn) Forecast, by Administration, 2017–2031
Table 25: Latin America Intragastric Balloons Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 26: Middle East & Africa Intragastric Balloons Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 27: Middle East & Africa Intragastric Balloons Market Value (US$ Mn) Forecast, by Duration, 2017–2031
Table 28: Middle East & Africa Intragastric Balloons Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 29: Middle East & Africa Intragastric Balloons Market Value (US$ Mn) Forecast, by Administration, 2017–2031
Table 30: Middle East & Africa Intragastric Balloons Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 1: Global Intragastric Balloons Market Value (US$ Mn) Forecast, 2017–2031
Figure 2: Global Intragastric Balloons Market Value Share, by Duration, 2022
Figure 3: Global Intragastric Balloons Market Value Share, by Type, 2022
Figure 4: Global Intragastric Balloons Market Value Share, by Administration, 2022
Figure 5: Global Intragastric Balloons Market Value Share, by End-user, 2022
Figure 6: Global Intragastric Balloons Market Value Share Analysis, by Duration 2022 and 2031
Figure 7: Global Intragastric Balloons Market Attractiveness Analysis, Duration, 2023–2031
Figure 8: Global Intragastric Balloons Market Value Share Analysis, by Type 2022 and 2031
Figure 9: Global Intragastric Balloons Market Attractiveness Analysis, Type, 2023–2031
Figure 10: Global Intragastric Balloons Market Value Share Analysis, by Administration 2022 and 2031
Figure 11: Global Intragastric Balloons Market Attractiveness Analysis, Administration, 2023–2031
Figure 12: Global Intragastric Balloons Market Value Share Analysis, by End-user 2022 and 2031
Figure 13: Global Intragastric Balloons Market Attractiveness Analysis, End-user, 2023–2031
Figure 14: Global Intragastric Balloons Market Value Share Analysis, by Region, 2022 and 2031
Figure 15: Global Intragastric Balloons Market Attractiveness Analysis, by Region, 2023–2031
Figure 16: North America Intragastric Balloons Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 17: North America Intragastric Balloons Market Value Share Analysis, by Country, 2022 and 2031
Figure 18: North America Intragastric Balloons Market Attractiveness Analysis, by Country, 2023–2031
Figure 19: North America Intragastric Balloons Market Value Share Analysis, by Duration 2022 and 2031
Figure 20: North America Intragastric Balloons Market Attractiveness Analysis, Duration, 2023–2031
Figure 21: North America Intragastric Balloons Market Value Share Analysis, by Type 2022 and 2031
Figure 22: North America Intragastric Balloons Market Attractiveness Analysis, Type, 2023–2031
Figure 23: North America Intragastric Balloons Market Value Share Analysis, by Administration 2022 and 2031
Figure 24: North America Intragastric Balloons Market Attractiveness Analysis, Administration, 2023–2031
Figure 25: North America Intragastric Balloons Market Attractiveness Analysis, End-user, 2023–2031
Figure 26: North America Intragastric Balloons Market Value Share Analysis, by End-user 2022 and 2031
Figure 27: Europe Intragastric Balloons Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 28: Europe Intragastric Balloons Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 29: Europe Intragastric Balloons Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 30: Europe Intragastric Balloons Market Value Share Analysis, by Duration 2022 and 2031
Figure 31: Europe Intragastric Balloons Market Attractiveness Analysis, Duration, 2023–2031
Figure 32: Europe Intragastric Balloons Market Value Share Analysis, by Type, 2022 and 2031
Figure 33: Europe Intragastric Balloons Market Attractiveness Analysis, Type, 2023–2031
Figure 34: Europe Intragastric Balloons Market Value Share Analysis, by Administration 2022 and 2031
Figure 35: Europe Intragastric Balloons Market Attractiveness Analysis, Administration, 2023–2031
Figure 36: Europe Intragastric Balloons Market Value Share Analysis, by End-user, 2022 and 2031
Figure 37: Europe Intragastric Balloons Market Attractiveness Analysis, End-user, 2023–2031
Figure 38: Asia Pacific Intragastric Balloons Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 39: Asia Pacific Intragastric Balloons Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 40: Asia Pacific Intragastric Balloons Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 41: Asia Pacific Intragastric Balloons Market Value Share Analysis, by Duration 2022 and 2031
Figure 42: Asia Pacific Intragastric Balloons Market Attractiveness Analysis, Duration, 2023–2031
Figure 43: Asia Pacific Intragastric Balloons Market Value Share Analysis, by Type, 2022 and 2031
Figure 44: Asia Pacific Intragastric Balloons Market Attractiveness Analysis, Type, 2023–2031
Figure 45: Asia Pacific Intragastric Balloons Market Value Share Analysis, by Administration 2022 and 2031
Figure 46: Asia Pacific Intragastric Balloons Market Attractiveness Analysis, Administration, 2023–2031
Figure 47: Asia Pacific Intragastric Balloons Market Value Share Analysis, by End-user, 2022 and 2031
Figure 48: Asia Pacific Intragastric Balloons Market Attractiveness Analysis, End-user, 2023–2031
Figure 49: Latin America Intragastric Balloons Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 50: Latin America Intragastric Balloons Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 51: Latin America Intragastric Balloons Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 52: Latin America Intragastric Balloons Market Value Share Analysis, by Duration 2022 and 2031
Figure 53: Latin America Intragastric Balloons Market Attractiveness Analysis, Duration, 2023–2031
Figure 54: Latin America Intragastric Balloons Market Value Share Analysis, by Type, 2022 and 2031
Figure 55: Latin America Intragastric Balloons Market Attractiveness Analysis, Type, 2023–2031
Figure 56: Latin America Intragastric Balloons Market Value Share Analysis, by Administration 2022 and 2031
Figure 57: Latin America Intragastric Balloons Market Attractiveness Analysis, Administration, 2023–2031
Figure 58: Latin America Intragastric Balloons Market Value Share Analysis, by End-user, 2022 and 2031
Figure 59: Latin America Intragastric Balloons Market Attractiveness Analysis, End-user, 2023–2031
Figure 60: Middle East & Africa Intragastric Balloons Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 61: Middle East & Africa Intragastric Balloons Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 62: Middle East & Africa Intragastric Balloons Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 63: Middle East & Africa Intragastric Balloons Market Value Share Analysis, by Duration 2022 and 2031
Figure 64: Middle East & Africa Intragastric Balloons Market Attractiveness Analysis, Duration, 2023–2031
Figure 65: Middle East & Africa Intragastric Balloons Market Value Share Analysis, by Type, 2022 and 2031
Figure 66: Middle East & Africa Intragastric Balloons Market Attractiveness Analysis, Type, 2023–2031
Figure 67: Middle East & Africa Intragastric Balloons Market Value Share Analysis, by Administration 2022 and 2031
Figure 68: Middle East & Africa Intragastric Balloons Market Attractiveness Analysis, Administration, 2023–2031
Figure 69: Middle East & Africa Intragastric Balloons Market Value Share Analysis, by End-user, 2022 and 2031
Figure 70: Middle East & Africa Intragastric Balloons Market Attractiveness Analysis, End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Intragastric Balloons Market
*86 figures and 60 tables includes